Payne Christopher D 4

What Happened Christopher D. Payne, a director of Hims & Hers Health, converted a total of 14,343 restricted stock units (RSUs) into Class A common shares in mid‑June 2026. The Form 4 lists conversions on 2026-06-11 (3,656 RSUs) and 2026-06-15 (10,040 RSUs and 647 RSUs). The transactions are reported as derivative conversions (transaction code M) and show no cash consideration ($0) in the filing.

Key Details

• Transaction dates and amounts: 6/11/2026 — 3,656 RSUs; 6/15/2026 — 10,040 RSUs and 647 RSUs; total converted = 14,343 shares.
• Reported prices/consideration: Acquisitions listed as N/A; disposals listed at $0 (derivative conversion), indicating no cash sale recorded in the Form 4.
• Shares owned after transaction: Not specified in the filing.
• Footnotes of note:
  • RSUs represent a contingent right to one share per RSU and were granted under the director compensation policy in lieu of Q1 2026 cash fees (foregone cash $14,875; grant price $22.98).
  • Vesting references: service-based schedule over 3 years (1/3 vested 6/15/2025, 1/3 on 6/15/2026, 1/3 on 5/15/2027); these RSUs vested per the company’s vesting rule noted in the filing.
• Timeliness: Form filed 2026-06-15 covering transactions on 6/11 and 6/15; the filing itself does not flag lateness.

Context

• These were conversions of RSUs to shares (transaction code M). The filing shows no sale or cash proceeds — this reflects issuance/vesting/conversion of director RSUs rather than an open‑market purchase or sale. Such filings document compensation being settled in equity; they are routine for directors receiving RSU grants.